Mar 9, 2026 · 2h 28m
Engineered T-cells and CRISPR technology revolutionize modern cancer treatment
Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
By programming the immune system to fight tumors, genetic engineering is shifting oncology from toxic treatments to precise, biological cures.
- 1Genetically engineered CAR T-cells can be programmed to recognize and destroy specific cancer cells with high precision.
Don't miss
Dr. Alex Marson explains how CRISPR technology is used to precisely rewrite T-cell DNA for targeted cancer therapy.
The brief
Modern oncology is undergoing a quiet revolution as researchers move beyond chemotherapy to enlist the body's own immune system. Dr. Alex Marson explains how scientists are now reprogramming human cells to hunt down and destroy tumors.
At the center of this breakthrough are T-cells, the adaptive immune system's specialized warriors. By using CRISPR gene editing, scientists can rewrite DNA to create CAR T-cells, essentially supercharging them to target specific cancer proteins.
While these advanced immunotherapies offer unprecedented hope for curing once-terminal cancers, they also raise critical ethical questions. The ability to edit human DNA brings a responsibility to carefully navigate the boundaries of heritable gene editing.
Beyond high-tech clinical interventions, daily lifestyle choices remain a foundational defense. Simple, actionable habits significantly support innate immunity and lower the baseline risk of developing cellular mutations in the first place.
Featuring
Mentioned
T cell
DNAListen to the full episode and explore every guest, topic, and moment on PodLume.